Henry L. Hudson
- Ophthalmology top 0.5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Epidemiology
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Co-authors
- Steven E. FeldonPeter K. KaiserSusan SchneiderKang ZhangDavid M. BrownHoward ShapiroNisha R. AcharyaFrank G. Holz
- Topics
- Retinal Diseases and Treatments (14 papers)Retinal Imaging and Analysis (8 papers)Glaucoma and retinal disorders (6 papers)
- Partner nations
- United StatesGermany
In The Last Decade
Henry L. Hudson
23 papers receiving 906 citations
Peers
Comparison fields: 5 of 68
- Ophthalmology 760
- Radiology, Nuclear Medicine and Imaging 527
- Epidemiology 138
- Molecular Biology 116
- Pathology and Forensic Medicine 116
Countries citing papers authored by Henry L. Hudson
This map shows the geographic impact of Henry L. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry L. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry L. Hudson more than expected).
Fields of papers citing papers by Henry L. Hudson
This network shows the impact of papers produced by Henry L. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry L. Hudson. The network helps show where Henry L. Hudson may publish in the future.
Co-authorship network of co-authors of Henry L. Hudson
This figure shows the co-authorship network connecting the top 25 collaborators of Henry L. Hudson. A scholar is included among the top collaborators of Henry L. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry L. Hudson. Henry L. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 19 | |
| 3 | Radical: 24-month Results Of A Phase II Exploratory Randomized Clinical Trial Of Reduced-fluence vPDT-anti-VEGF-dexamethasone In AMD | 0 |
| 4 | 76 | |
| 5 | 34 | |
| 6 | 306 | |
| 7 | 25 | |
| 8 | 6 | |
| 9 | Results of a Phase I, Dose–Escalation, Safety, Tolerability, and Bioactivity Study of Intravitreous VEGF Trap in Patients With Neovascular Age–Related Macular Degeneration | 1 |
| 10 | 80 | |
| 11 | Clinical Outcomes of Two Open–Label Pharmacokinetic Studies With Anecortave Acetate in Patients With Exudative Age–Related Macular Degeneration (AMD) | 2 |
| 12 | 25 | |
| 13 | 14 | |
| 14 | 4 | |
| 15 | 18 | |
| 16 | 49 | |
| 17 | 57 | |
| 18 | Pituitary tumor volume as a predictor of postoperative visual field recovery. Quantitative analysis using automated static perimetry and computed tomography morphometry. | 18 |
| 19 | 4 | |
| 20 | 13 |
About Henry L. Hudson
Henry L. Hudson is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 25 papers that have together received 950 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (14 papers), Retinal Imaging and Analysis (8 papers) and Glaucoma and retinal disorders (6 papers). The work is most often cited by research in Ophthalmology (760 citations), Radiology, Nuclear Medicine and Imaging (527 citations) and Pathology and Forensic Medicine (116 citations). Henry L. Hudson has collaborated with scholars based in United States and Germany. Frequent co-authors include Steven E. Feldon, Peter K. Kaiser, Susan Schneider, Kang Zhang, David M. Brown, Howard Shapiro, Nisha R. Acharya, Frank G. Holz, Lawrence J. Singerman and Jason S. Slakter. Their work appears in journals such as Ophthalmology, Journal of neurosurgery and American Journal of Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.